Admiral MacDonald RN
- Posts:
- 19,451
- Group:
- Banned
- Member
- #62
- Joined:
- September 24, 2003
|
http://www.newscientist.com/article/mg20026803.800-menopausal-men-could-get-sexual-boost-from-hrt.html?DCMP=ILC-hmts&nsref=specbtm7_head_'Menopausal'%20men%20could%20get%20sexual%20boost%20from%20HRT
- Quote:
-
'Menopausal' men could get sexual boost from HRT 29 October 2008 From New Scientist Print Edition. Subscribe and get 4 free issues. Linda Geddes
TIREDNESS, depression and lack of libido all seem inevitable parts of male ageing, but what if an age-related lack of testosterone is at the root of all these symptoms? Increasingly, doctors say such an "andropause" exists and that its effects may go beyond feeling a bit tired - obesity and diabetes also appear to be linked. The good news is that testosterone supplements might help treat the problem.
Though testosterone is sometimes prescribed for ageing men in Europe and the US, until recently even the existence of andropause was considered controversial. Treating it was seen by many as unnecessary and potentially harmful because of concerns that testosterone supplements could contribute to prostate cancer by driving the growth of cancerous cells.
Now that attitude is starting to change. While many researchers and doctors still dislike the use of the word andropause - because it implies equivalence with menopause and yet does not affect all men - there is an acceptance that testosterone levels decline with age, resulting in testosterone deficiency - or late-onset hypogonadism (LOH) - in around 20 per cent of men over 65. "Age-related declines in testosterone are real," says Adrian Dobs of Johns Hopkins University in Baltimore, Maryland. "If a man has signs of hypogonadism then treatment should be considered."
Meanwhile, a handful of recent studies have linked low testosterone to the development of type 2 diabetes, obesity and cardiovascular disease. Other research indicates that some of the fears about testosterone supplements increasing the risk of prostate cancer may have been unfounded (See "Doesn't testosterone drive cancer?").
As a result, the International Association for the Study of the Aging Male, the International Society of Andrology, the European Association of Urology and the American Society of Andrology have updated their guidelines on who to screen for testosterone deficiency and how to treat it (Journal of Andrology, DOI: 10.2164/jandrol.108.006486).
In particular, they recommend measuring testosterone in all men who have both type 2 diabetes and symptoms of testosterone deficiency (see list of symptoms), and in those with erectile dysfunction or low libido. "This is a major change," says Andre Araujo, director of epidemiology at the New England Research Institutes in Watertown, Massachusetts. "That puts a lot of people in the category of being screened for low testosterone."
"It is going to pick up a lot of men with low testosterone who previously would have been sat at home without their doctor investigating it," says Hugh Jones, professor of andrology at the University of Sheffield, UK. That in turn means many more men could be given hormone replacement therapy.
The authors of the guidelines stress that, unlike menopause in women, not all men experience andropause and only those who show symptoms of testosterone deficiency should be considered for therapy. However, they also emphasise the role testosterone may play in causing these symptoms. In the case of erectile dysfunction, doctors are realising that drugs like Viagra, which increase blood flow to the penis, may not work if men also have low testosterone. Meanwhile, there is now strong evidence that low testosterone is linked with diabetes and obesity, and some evidence that boosting testosterone can alleviate the symptoms of diabetes.
"There are wide-reaching effects of testosterone on metabolism and vascular health," says Jones. He has shown that giving a testosterone gel to men who have both type 2 diabetes and testosterone deficiency improves their sensitivity to insulin, the hormone that controls blood sugar levels, in a study that was funded by ProStrakan of Galashiels, UK, a company that sells testosterone gel. Jones believes that the guidelines do not go far enough and suggests measuring testosterone levels in all men with diabetes, regardless of whether they also show symptoms of testosterone deficiency.
But this is controversial. Araujo says it can be difficult to disentangle whether low testosterone is a cause or a symptom of diabetes, so there is no evidence that boosting testosterone will be of any benefit to men who have no symptoms of deficiency. "There is no point in screening men for low testosterone at that point - levels will be low as a consequence of their diabetes," he says.
Eberhard Nieschlag of the University of Münster in Germany, who edited the new guidelines, raises the possibility of giving testosterone to kick-start weight loss or alleviation of diabetes symptoms - but then stopping treatment. "If you give testosterone to a man who lacks it, it is much easier for him to lose weight, but this should by no means become a treatment for life," he says.
All the experts contacted by New Scientist also warn against using testosterone supplements as a substitute for weight loss, healthy eating or conventional diabetes drugs, especially because treating the causes of the underlying disease may cause testosterone to rise back to normal on its own. "It is important to treat the underlying disease as well," says Dobs.
Will there ever be a case for screening all men for testosterone deficiency once they get to a certain age? In the past two years several studies (see, for example, Archives of Internal Medicine, vol 166, p 1660, and The Journal of Clinical Endocrinology and Metabolism, DOI: 10.1210/jc.2007-1792) have indicated that men with low levels of testosterone are more likely to die earlier than men with normal testosterone levels - even if they have no other symptoms. However, there is as yet little evidence that treating testosterone deficiency would prevent these deaths, and widespread agreement that there is not enough evidence to justify screening all men over 50.
Larger studies are also needed to confirm that treating low testosterone, even in people with symptoms, results in a better quality of life.
"There are many clinicians who are treating many men with testosterone replacement and the men feel better," says Gail Laughlin at the University of California, San Diego, who led one of the studies linking low testosterone to early mortality. "But for many years we treated women with oestrogen with the idea that it was good for women, and as we now know, the clinical trials have not supported that belief. So we need bigger trials."
The US National Institutes of Health is now funding a trial that should answer many of these questions, although results are not expected for several years.
But even if widespread testosterone screening is deemed unnecessary, Nieschlag believes there should be more general awareness about the symptoms of testosterone deficiency, which he says should never simply be dismissed as unstoppable features of old age. "It may be depression, fatigue, a lack of interest [in sex], a broken bone - with all these things doctors should be aware that a lack of testosterone could be behind it," he says.
Doesn't testosterone drive cancer? Fears that testosterone supplements increase the risk of prostate cancer have troubled doctors for years. Now medical guidelines on treating testosterone deficiency in older men firmly support the idea that it does not.
Testosterone drives the growth of cancer cells in men with prostate cancer, so for many years doctors feared that it might also turn "subclinical", early-stage prostate cancer - which many elderly men have - into the full-blown disease. "Twenty years ago, if you had talked to a urologist about giving an ageing man testosterone they would have said you were committing a crime," says Eberhard Nieschlag of the University of Münster in Germany, who edited the new guidelines. But evidence is now accumulating that testosterone plays a much smaller role in prostate cancer than thought (Journal of the National Cancer Institute, DOI: 10.1093/jnci/djm323).
The guidelines, which recommend that the number of men screened and perhaps treated for testosterone deficiency should be increased (see main article), say there is no conclusive evidence that testosterone therapy increases the risk of contracting prostate cancer, or converts subclinical cancer into a detectable disease.
The guidelines also suggest that men who have previously suffered from prostate cancer but have been given the all-clear should be allowed to receive testosterone replacement therapy if they have symptoms of low testosterone levels.
"There has been a major pendulum swing regarding the use of testosterone therapy in men who have been successfully treated for prostate cancer," says Andre Araujo of the New England Research Institutes in Watertown, Massachusetts.
That doesn't mean testosterone supplements are without risk. Men should be checked for any signs of prostate cancer before starting therapy and at regular intervals afterwards. Testosterone replacement can also lead to an increase in the number of red blood cells - a condition known as polycythemia - which increases the risk of stroke or blood clots. "Whatever you're doing, you need to make sure the patient understands the risks and benefits," says Christina Wang of the University of California at Los Angeles, who co-authored the new guidelines.
Fairdinkum .... am I just put it down to being middle aged , bitter and twisted , and no longer giving a toss and jiust becoming jaded and lazy in my middle age .....
Edited by somerled, Oct 31 2008, 07:16 AM.
|